Medicinal chemistry of the human adenosine A3 receptor

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 182-189

  Van Tilburg, Erica W ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

A3 receptor; New ligands

Indexed keywords

3 (2 PYRIDINYL)ISOQUINOLINE DERIVATIVE; 4 METHOXY N [2 (2 PYRIDINYL)QUINAZOLIN 4 YL]BENZAMIDE; 5' DEOXY 6 N (3 IODOBENZYL) 5 METHYLTHIOADENOSINE; 6 N (3 IODOBENZYL)ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BRAIN PROTECTION; CONFERENCE PAPER; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HEART PROTECTION; HUMAN; LIGAND BINDING; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0032453132     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<182::AID-DDR15>3.0.CO;2-E     Document Type: Conference Paper

References (42)

1. aclenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 43:1089-1093.
2. De Zwart MAH, Goot Hvd, Timmennan H. 1988. STithesis and copper dependent antimycoplasmal activity of l-amino-3-(2-pyridyl)isoquinoline derivatives 1 Amides. J Med Chem 31:716-722.
3. Dods RE Roth JS. 1969. Halogenation of nucleosides by (halomethylene) dimethylene ammonium halides. Tetrahedron Lett:165-168.
4. Gallo-Rodriguez C, JiX, Melman N, Siegman BD, Sanders LH, Orlina J, Fischer B, Pu Q, Olah ME, Van Galen PJM, Stiles GL, Jacobson KA. 1994. Stmcture-activity relationships of N -benzyladenosine5'-uronamides as As-selective adenosine agonists. J Med Chem 37:636-646.
5. Hannon JP, Pfannkiiche HJ, Fozard JR. 1995. A role for mast cells in adenosine AS receptor-mediated hypotension in the rat. Br J Pharmacol 115:945-952.
6. IJzerman AP, Van der Wenden EM, von Frijtag Drabbe Künzel JK, Mathôt RAA, Danhof M, Borea PA, Varani K. 1994. Partial agonism of theophyIline-7-riboside on adenosine receptors. Naunyn Schmiedebergs Arch Phannacol 350:638-645.
7. Jacobson KA. 1998. Adenosine AS receptors: novel ligands and paradoxal effects. TIPS 19:184-191.
8. Jacobson KA, van Galen PJM, Williams M. 1992. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35:407-122.
9. Jacobson KA, Kirn O, Siddiqi SM, Olah ME, Stiles GL, Von Lubitz DKJE. 1995. As-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699.
10. Jacobson KA, Chakravarty PK, Johnson RG, Norton R. 1996a. Novel selective non-xanthine AS adenosine receptor antagonists. Drag Dev Res 37:131.
11. Jacobson KA, Von Lubitz DKJE, Daly JW, Fredholm BB. 1996b. Adenosine receptor ligands: differences with acute versus chronic treatment. TIPS 17:108-113.
12. Jacobson MA, Bai TR. 1997. The role of adenosine in asthma. In: Jacobson KA, Jarvis ME editors. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, Inc. p 315-331.
13. Jarvis ME Schultz R, Hutchison AJ, Hoi Do U, Sills M, Williams M. 1989. [3H]-CGS21680, a selective A2 adenosine receptor agonist directly labels A£ receptors in rat brain. J Pharmacol Exp Ther 251:888-893.
14. Kikugawa K, Ichino M. 1971. Direct halogenation of sugar moiety of nucleosides. Tetrahedron Lett 2:87-90.
15. Kirn HO, Ji X-d, Melman N, Olah ME, Stiles GL, Jacobson KA. 1994a. Selective ligands for rat AS adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives. J Med Chem 37:4020-4030.
16. Kirn HO, Siddiqi SM, Olah ME, Stiles GL, Jacobson KA. 1994b. 2Substitution of N -benzyladenosine-5'-uronamides enhances selectivity for AS adenosine receptors. J Med Chem 37:3614-3621.
17. Kim J, Ji XD, Melman N, Olah ME, Stiles GL, Jacobson KA. 1994c. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors. J Med Chem 37:3373-3382.
18. Kim HO, Ji X, Jacobson KA. 1996. Derivatives of the triazoloquinazoline adenosine antagonist. CGS15943) are selective for the human A3 receptor subtype. J Med Chem 39:4142-1148.
19. Linden J. 1994. Cloned adenosine AS receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sei 15:298-306.
20. Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fïnk JS, Reppert SM. 1993. Molecular cloning and functional expression of a sheep Aa adenosine receptor with widespread tissue distribution. Mol Pharmacol 44:524-532.
21. Liu G-S, Downey JM, Cohen MV 1997. Adenosine, ischemia, and preconditioning. In: Jacobson KA, Jarvis ME, editors. Purinergic approaches in experimental therapeutics. New York: \Yiley-Liss, Inc. p 153-172.
22. Lorenzen A, Fuss M, Vogt H, Schwabe U. 1993. Measurement of guanine nucleotide-binding protein activation by AI adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O(3-[MS]thio)triphosphate binding. Mol Pharmacol 44:115-123.
23. Lorenzen A, Guerra L, Vogt H, Schwabe U. 1996. Interaction of full and partial agonists of the AI adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol Phannacol 49:915-926.
24. Muijlwijk-Koezen JEv, Timmerman H, Link R, Goot Hvd, IJzerman AE 199Sa. A novel class of adenosine AS receptor ligands I 3-(2pyridinyl)isoquinoline derivatives. J Med Chem 41:3987-3993.
25. Muijlwijk-Koezen JEv, Tinime'rman II, Link R, Goot Hvd, IJzerman AE 199Sb. A novel class of adenosine AS receptor ligands Structure affinity profile of a series of isoquinoline and quinazoline compounds. J Med Chem 41:3994-4000.
26. Olah ME, Gallo-Rodriguez C, Jacobson KA, Stiles GL. 1994.125I-4Aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor. Mol Pharmacol 45:978-982.
27. Palmer TM, Gettys TW, Stiles GL. 1995. Differential interaction with and regulation of multiple G-proteins by the rat As adenosine receptor. J Biol Chem 270:16895-16902.
28. Pirovano IM, IJzerman AP, Van Galen PJM, Soudijn W. 1989. The influence of molecular structure of N6-((u-aminoalkyl)-adenosines on adenosine receptor affinity and intrinsic activity. Eur J Pharmacol 172:185-193.
29. Ramkumar V, Stiles GL, Beaven MA, Ali H. 1993. The AsAR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
30. Robins MJ, Hansske F, Wnuk SE Kanai T. 1992. Nucleic acid related compounds 66. Improved synthesis of 5'-chloro-5'-deoxy- and 5'S-aryl. or aIkyl)-5'-thionucleosides. Can J Chem 69:1468-1474.
31. Salvatore CA, Jacobson MA, Taylor HE, Linden J, Johnson RG. 1993. Molecular cloning and characterization of the human AS adenosine receptor. Proc Natl Acad Sei USA 15:10365-10369.
32. Srivastava PC, Robins RK, Meyer RBJ. 1988. Synthesis and properties of purine nucleosides and nucleotides. In: Townsend LB, editor. Chemistry of nucleosides and nucleotides, 1. New York: Plenum Press, p 113-282.
33. Taylor MD, Moos WH, Hamilton H\V, Szotek DS, Patt WC, Badger EW, Bristol JA, Bruns RE Heffner TG, Mertz TE. 1986. Ribosemodified adenosine analogues as adenosine receptor agonists. J Med Chem 29:346-353.
34. Van der Wenden EM, Camielli M, Roelen, HCPF, Lorenzen A, von Frijtag von Drabbe Künzel JK, IJzerman AE 1998. 5'-Substituted adenosine analogs as new high-affinity partial agonists for the adenosine AI receptor. J Med Chem 41:102-108.
35. Van Galen PJM, Van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, IJzerman AP, Stiles GL, Jacobson KA. 1994. A binding site model and structure-activity relationships for the rat As adenosine receptor. Mol Pharmacol 45:1101-1111.
36. Van Rliee AM, Jiang JL, Melman N, Olah ME, Stiles GL, Jacobson KA. 1996. Interaction of 1,4-dihydropyridine and pyridine dériva-lives with adenosine receptors: selectivity for A.J receptors. J Med Chem 39:2980-2989.
37. Van Schaick EA, Jacobson KA, Kim HO, IJzerman AP, Danhof M. 1996. Hemodynamic effects and histamine release elicited by the selective adenosine AS receptor agonist 2-Cl-IB-MECA in conscious rats. Eur J Pharmacol 308:311-314.
38. Van Tilburg EW, Von Frijtag Drabbe Künzel J, de Groote M, Vollinga RC, Lorenzen A, IJzerman AR 1998. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human Aj adenosine receptor, (submitted).
39. Von Lubitz DKJE. 1997. Adenosine and acute treatment of cerebral ischemia and stroke - "put out more flags." In: Jacobson KA, Jarvis MR editors. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, Inc. p 449-470.
40. Von Lubitz DKJE, Lin RCS.-Popik P, Carter MR Jacobson KA. 1994. Adenosine AS receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
41. Von Lubitz DKJE, Carter ME Deutsch SI, Lin RCS, Mastropaolo J, Meshulam Y, Jacobson KA. 1995. The effects of adenosine AS receptor stimulation on seizures in mice. Eur J Pharmacol 275:23-29.
42. Zhou QY, Li CY, Olah ME, Johnson RA, Stiles GL, Ci%-elli O. 1992. Molecular cloning and characterization of an adenosine receptor: the AS adenosine receptor. Proc Natl Acad Sei USA 89:7432-7436.